| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 08/17/2006 | CA2597541A1 Crystal of 4(3h)-quinazolinone derivative |
| 08/17/2006 | CA2597395A1 Method and composition for treating mammalian diseases and injuries caused by the over-expression of peroxynitrite |
| 08/17/2006 | CA2597067A1 Use of an scd-1 inhibitor to reduce adverse weight gain arising from drug therapy |
| 08/17/2006 | CA2596485A1 Combination of organic compounds |
| 08/17/2006 | CA2596422A1 6-ether/thioether-purines as topoisomerase ii catalytic inhibitors and their use in therapy |
| 08/17/2006 | CA2596407A1 Methods for treating parkinson's disease |
| 08/16/2006 | EP1690852A1 Novel target protein of anticancer agent and novel anticancer agent (spnal) corresponding thereto |
| 08/16/2006 | EP1690550A1 Therapeutic agent for mesothelioma |
| 08/16/2006 | EP1690549A1 Immunotherapic agent which is used for the combined treatment of tuberculosis together with other pharmaceuticals |
| 08/16/2006 | EP1690545A2 A combination therapy for HIV infections |
| 08/16/2006 | EP1689782A1 Anti-igfr1 antibody therapeutic combinations |
| 08/16/2006 | EP1689714A2 Therapeutic use of pyridinium compounds to modulate naadp activity |
| 08/16/2006 | EP1689436A1 TREATMENT OF RHEUMATOID ARTHRITIS WITH HYPOXIA-INDUCIBLE FACTOR a ANTAGONISTS |
| 08/16/2006 | EP1689416A1 Disinfecting composition and methods of making and using same |
| 08/16/2006 | EP1689411A2 Graduated estrogen contraceptive |
| 08/16/2006 | EP1689405A1 Thioridazine and derivatives thereof for reversing anti-microbial drug-resistance |
| 08/16/2006 | EP1689402A1 Combination therapy comprising the use of et-743 and doxorubicin for treating cancer |
| 08/16/2006 | EP1689401A1 Method for reducing pain |
| 08/16/2006 | EP1689384A1 Complexes of cyclic polyaza chelators with cations of alkaline earth metals for enhanced biological activity |
| 08/16/2006 | EP1689382A1 Pharmaceutical composition comprising a beta-3-adrenoceptor agonist and an agent intervening in the prostaglandin metabolism |
| 08/16/2006 | EP1689381A1 Pharmaceutical composition comprising i.a. vitamin c, magnesium, green tea extract for retarding cardiovascular diseases |
| 08/16/2006 | EP1689361A2 Therapeutic combinations and methods including irm compounds |
| 08/16/2006 | EP1689359A2 Composition for the treatment of arthrosis/arthritis, especially for treating joints |
| 08/16/2006 | EP1689354A2 Amelioration of cataracts, macular degeneration and other ophthalmic diseases |
| 08/16/2006 | EP1689223A2 Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of asbestos-related diseases and disorders |
| 08/16/2006 | EP1575618B1 Dispersible pharmaceutical compositions |
| 08/16/2006 | EP1482948B1 Continuous sulfatase inhibiting progestogen hormone replacement therapy |
| 08/16/2006 | EP1469827A4 Polymorphs of sodium 4- (4-chloro-2-hydroxybenzoyl)amino butanoate |
| 08/16/2006 | EP1467707B1 Composition for easing human childbirth |
| 08/16/2006 | EP1450832B1 Lactic acid bacteria and their use for treating and preventing cancer |
| 08/16/2006 | EP1337247B1 Use of Gaboxadol for the treatment of premenstrual disorder, postnatal depression or postmenopausal related dysphoric disorder |
| 08/16/2006 | EP1292687B1 Regulated antigen delivery system (rads) involving bacteria |
| 08/16/2006 | EP1259234B1 3-heteroarylidenyl-2-indolinone compounds for modulating protein kinase activity and for use in cancer chemotherapy |
| 08/16/2006 | EP1227810B8 Treating cancer by increasing intracellular malonyl coa levels |
| 08/16/2006 | EP1198233B1 Sulfonamide and sulfamide substituted imidazoquinolines |
| 08/16/2006 | EP1183020B1 (3-trihalomethylphenoxy) (4-halophenyl) for the treatment of insulin resistance and type 2 diabetes |
| 08/16/2006 | EP1019075B9 Beta 2-adrenergic receptor agonists |
| 08/16/2006 | EP0977577B1 Compositions for the treatment of ards or irds containing 3-(cyclopropylmethoxy)-n-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy)benzamide and lung surfactant |
| 08/16/2006 | EP0917873B1 Eyedrops |
| 08/16/2006 | EP0527917B2 Use of adenosine and adenosine derivatives for anesthesia |
| 08/16/2006 | CN1820200A Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors |
| 08/16/2006 | CN1820078A Recombinant mutants of rhabdovirus and methods of use thereof |
| 08/16/2006 | CN1819846A Ophthalmic percutaneously absorbed preparation containing muscarinic receptor agonist |
| 08/16/2006 | CN1819845A Medicinal composition containing NF-kappa B decoy for treating and preventing respiratory diseases and method of using the same |
| 08/16/2006 | CN1819842A Treating effect of using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality |
| 08/16/2006 | CN1819840A Use of inhibitors of enzymes with APN and/or DPIV activity and pharmaceutical preparations of said inhibitors for the treatment and prevention of dermatological diseases involving the hyperproliferati |
| 08/16/2006 | CN1819825A Amino acid iodine composition, its production and use thereof |
| 08/16/2006 | CN1819822A Compositions containing substituted quinolines and substituted diphenyl sulfones and methods of use |
| 08/16/2006 | CN1818058A In vitro cell culturing method |
| 08/16/2006 | CN1817367A Activation and inhibition of the immune system |
| 08/16/2006 | CN1269839C Treatment with anti-ErbB2 antibodies |
| 08/16/2006 | CN1269820C Novel pyrrole derivatives as pharmaceutical agents |
| 08/16/2006 | CN1269529C Medicinal composition contaniing angiotensin invertase inhibitor and vitamin B |
| 08/16/2006 | CN1269528C Application of dipeptide base peptidase IV effector for reducing blood sugar level of mammal |
| 08/16/2006 | CN1269524C Thymosin augmentation of genetic immunization |
| 08/16/2006 | CN1269484C Serotonergic 5HT2 agonists for treating glaucoma |
| 08/16/2006 | CN1269483C Novel Use |
| 08/16/2006 | CN1269482C Application of Na-ion channel blocker and opium antalgesic in preparing synergic antalgic medicine for mammal |
| 08/15/2006 | USRE39239 Methods for treating early morning pathologies |
| 08/15/2006 | US7091333 Oligomers that hybridize to Inhibition of Apoptosis (IAP) polynucleotides and methods for using them to enhance apoptosis and treat proliferative diseases |
| 08/15/2006 | US7091319 IL-3 variant hematopoiesis fusion protein |
| 08/15/2006 | US7091310 Chemokine analogs for the treatment of human disease |
| 08/15/2006 | US7091241 Synergistic mixture; anticancer, antitumor agents |
| 08/15/2006 | US7091230 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders |
| 08/15/2006 | US7091223 Autoimmune diseases; anticancer agents |
| 08/15/2006 | US7091213 Phosphorus-containing compounds and uses thereof |
| 08/15/2006 | US7091208 Janus Kinase inhibitors and optionally mixed with antiinflammatory agents, for use as immunosuppresants for prophylaxis of lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, diabetes and graft versus host diseases |
| 08/15/2006 | US7091190 Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs |
| 08/15/2006 | US7091189 Medicament for treating lung cancer |
| 08/15/2006 | US7091182 Analyzing a blood sample for secretin level |
| 08/15/2006 | US7091006 Isolated nucleic acid of given sequence; use in identifying metabolic and neurological disorders |
| 08/15/2006 | US7090971 identifying a compound capable of modulating trans-glutaminase (TG) kinase activity by determining if it activates or inhibits TG2 kinase activity as indicated by a TG2 mediated phosphorylation of the TG2 kinase |
| 08/15/2006 | US7090871 Composition containing pyrrolizidine-alkaloid-free petasites |
| 08/15/2006 | US7090865 Preventing antibody-induced anemia by administering a complexes of bisphosphonate |
| 08/15/2006 | US7090843 immunotherapy; fusion proteins; antitumor agents; for treatment and prevention of hodgkin's disease |
| 08/15/2006 | US7090839 Method of treatment of human immunodeficiency diseases |
| 08/15/2006 | US7090835 Modified colony stimulating factor for treatment of hematopoietic disorder |
| 08/15/2006 | CA2274135C Novel therapeutic application of a thienycyclohexylamine derivative |
| 08/15/2006 | CA2213987C Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a nsaid |
| 08/15/2006 | CA2211612C [5-carboxamido or 5-fluoro]-[2',3'-unsaturated or 3'-modified]-pyrimidine nucleosides |
| 08/15/2006 | CA2200126C Treatment and prophylaxis of pancreatitis |
| 08/10/2006 | WO2006084174A2 Improved bioavailability and improved delivery of alkaline pharmaceutical drugs |
| 08/10/2006 | WO2006083042A1 Agent for prevention/treatment of neurodegenerative disease |
| 08/10/2006 | WO2006082974A1 Remedy for ischemic disease |
| 08/10/2006 | WO2006082821A1 Preventive or therapeutic agent for herpesvirus-related disease |
| 08/10/2006 | WO2006082500A1 Dosage forms providing controlled and immediate release of cholesteryl ester transfer protein inhibitors and immediate release of hmg-coa reductase inhibitors |
| 08/10/2006 | WO2006066121A3 Combination of a glycine transporter (glyt1) inhibitor and an antipsychotic for the treatment of symptoms of schizophrenia as well as its preparation and use thereof |
| 08/10/2006 | WO2006024492A3 Medical implant provided with inhibitors of atp synthesis |
| 08/10/2006 | WO2006024490A3 Methods and compositions for the treatment of cell proliferation |
| 08/10/2006 | WO2006024489A3 Methods and compositions for the treatment of cell proliferation |
| 08/10/2006 | WO2006023714A3 Dithiocarbamate derivatives and their use for treating cancer |
| 08/10/2006 | WO2005123069A3 Gram-positive carbapenem antibacterials and processes for their preparation |
| 08/10/2006 | WO2005115455A3 Methods and reagents for the treatment of immunoinflammatory disorders |
| 08/10/2006 | WO2005113749A3 Stem cell populations and methods of use |
| 08/10/2006 | WO2005062782A3 Non-animal product containing veterinary formulations |
| 08/10/2006 | WO2005055956A3 Method for improving insulin sensitivity by administering an inhibitor of antitrypsin |
| 08/10/2006 | WO2004050894A3 Heart failure gene determination and therapeutic screening |
| 08/10/2006 | WO2003065999A3 Proliferated cell lines and uses thereof |
| 08/10/2006 | US20060179496 Nucleic acid sequences differentially expressed in cancer tissue |
| 08/10/2006 | US20060179494 Non-human animal exhibiting bone metastasis of tumor cells |